U.S. Healthtech Stock News

Target (TGT) has been back in focus after several analyst upgrades coincided with a leadership shake-up under new CEO Michael Fiddelke and a reaffirmed 2025 earnings outlook that points to management confidence. See our latest analysis for Target. Those upgrades and leadership changes line up with a sharp swing in sentiment, with a 90 day share price return of 38.03% and a year to date share price return of 16.10%. This is despite the 1 year total shareholder return being a 1.80% decline and...

In February 2026, Alarm.com Holdings reported fourth‑quarter 2025 revenue of US$261.66 million and net income of US$34.73 million, taking full‑year revenue past US$1.01 billion alongside higher earnings per share. Management also outlined plans to keep investing in its EnergyHub and AI‑enabled SaaS platforms, while selectively pursuing acquisitions to reinforce growth. With this backdrop of earnings outperformance and a focus on high‑return SaaS and energy platforms, we’ll assess how the...

The U.S. Supreme Court’s decision to strike down Trump-era tariffs has put MasTec (MTZ) in focus, as investors weigh how lower import costs for key materials could influence the infrastructure contractor’s expense profile. See our latest analysis for MasTec. MasTec’s shares have been trending higher for some time, and the tariff ruling appears to fit into that story, with a 30 day share price return of 17.39% and a 1 year total shareholder return of 124.38% pointing to strong recent...

In February 2026, Douglas Emmett, Inc. reported fourth-quarter 2025 revenue of US$249.43 million and a net loss of US$6.84 million, alongside full-year 2025 revenue of US$1.00 billion and net income of US$16.27 million, with earnings per share from continuing operations of US$0.09. At the same time, analysts highlighted pressure on profitability from higher interest expense and flat occupancy assumptions, even as the CEO increased his shareholding with a 98,000-share purchase, underlining a...

Teva Pharmaceutical Industries (NYSE:TEVA) has drawn fresh attention after its recent trading performance, with the share price closing at US$34.22 as investors reassess the business and its earnings profile. See our latest analysis for Teva Pharmaceutical Industries. While the latest 1 day share price return of 0.32% decline looks minor in isolation, Teva Pharmaceutical Industries has posted a 30 day share price return of 7.58% and a 90 day share price return of 38.15%, alongside a 1 year...

Recently, Wall Street analysts issued more cautious forecasts for Webster Financial, pointing to slower sales trends over the past two years and expectations for a higher efficiency ratio that implies rising operating costs. This shift in sentiment raises questions about how increasing operating expenses might affect Webster Financial’s longer-term profitability and business priorities. Now we’ll explore how concerns about a rising efficiency ratio and operating costs could influence Webster...

OFG Bancorp (OFG) has caught investor attention after recent trading, with the share price at $42.66 and returns of 1.3% over the past day and 1.8% over the past week. See our latest analysis for OFG Bancorp. Beyond the latest move, OFG Bancorp’s recent 14.83% 1 month share price return and 5.38% 1 year total shareholder return point to building momentum on top of solid multi year gains. If this banking stock has you thinking about what else might be setting up for long term compounding, now...

Square AI launch and ecosystem expansion put Block in focus Block (XYZ) is back on investor watchlists after a flurry of product moves, including the UK launch of Square AI, new bitcoin hardware initiatives, and deeper ties with platform partners such as Amazon and Apple. The company is rolling out Square AI to UK sellers as a free conversational assistant built into the existing Square platform. It is aimed at helping small and medium sized businesses turn their own data into quicker,...

Chubb recently announced that Scott Henck, currently Executive Vice President and Chief Actuary for North America, has been appointed Senior Vice President, Chubb Group and Chief Actuary effective April 1, 2026, succeeding long-time industry veteran Paul O’Connell, while Cynthia Bentley steps up to become Executive Vice President and North America Chief Actuary. This leadership transition places two deeply experienced internal actuaries in charge of global and North America reserving,...

Iovance Biotherapeutics (IOVA) is back in focus after real world data for its recently approved Amtagvi therapy showed a 44% confirmed objective response rate and 73% disease control in advanced melanoma patients. See our latest analysis for Iovance Biotherapeutics. Those Amtagvi results come as Iovance’s 7 day share price return of 11.67% and 90 day share price return of 14.80% contrast with a 1 year total shareholder return decline of roughly 50%. Recent momentum is improving from a weak...

If you are wondering whether Amgen's current share price lines up with its underlying value, you are not alone. This article will walk through what that might look like using several valuation tools. Amgen recently closed at US$374.75, with returns of 1.5% over 7 days, 8.7% over 30 days, 14.4% year to date, 27.6% over 1 year, 76.2% over 3 years and 94.9% over 5 years. This gives investors plenty to think about in terms of changing risk and return expectations. Recent coverage on Amgen has...

If you are wondering whether Fiverr International's current share price really reflects what the business is worth, you are not alone. This article will help you frame that question clearly. The stock finished the last session at US$11.68, with returns of an 18.5% decline over 7 days, 27.7% decline over 30 days, 40.7% decline year to date, 54.6% decline over 1 year, 70.8% decline over 3 years and 95.7% decline over 5 years. These moves have kept Fiverr in focus for investors looking at how...

Large institutional investors, including Morgan Stanley, Goldman Sachs, BlackRock, and ARK Invest, have recently increased their stakes in Bitmine Immersion Technologies (BMNR), as the company expanded its Ethereum holdings and launched new ETH staking initiatives. See our latest analysis for Bitmine Immersion Technologies. Despite the recent ETH accumulation and validator launch, Bitmine Immersion Technologies’ 30 day share price return of 30.1% and year to date share price return of 35.46%...

Why Digital Realty Trust Is On Investors’ Radar Today Digital Realty Trust (DLR) has drawn fresh attention after recent share price moves, with the stock showing a mix of short term pressure and longer term resilience that has some investors reassessing its data center exposure. See our latest analysis for Digital Realty Trust. Digital Realty Trust’s share price has eased in the last week, with a 1 day share price return of 0.69% decline and a 7 day share price return of 2.92% decline...

Halliburton Company’s board declared a first-quarter 2026 cash dividend of US$0.17 per share, payable on March 25, 2026, to shareholders of record as of March 4, while also appointing Timothy A. Leach to its board and key committees following his December 2025 board accession. The company’s stronger-than-expected fourth-quarter 2025 earnings, driven by cost reductions and a firm international business, highlight how operational efficiency and geographic mix are shaping Halliburton’s cash...

If you are wondering whether Newegg Commerce’s recent share price makes sense or feels stretched, you are not alone. That is exactly what this article will unpack for you. The stock last closed at US$50.83, with returns of 9.0% over the past week, 3.8% over the past month, a 2.8% decline year to date, and 461.9% over the past year. This naturally raises questions about how much of this is already reflected in the price. Recent coverage has highlighted Newegg Commerce’s position as a focused...

ServiceNow (NOW) has been back in focus after CEO William McDermott bought US$3 million of shares and other leaders scrapped planned stock sales, reinforcing an internal show of confidence during AI driven sector worries. See our latest analysis for ServiceNow. The market reaction to that insider show of faith comes after a sharp reset, with a 30 day share price return of 21.67% and a 90 day share price return of 36.10%. This leaves ServiceNow at US$104.27 and a 1 year total shareholder...

Energy Transfer (NYSE:ET) has begun large scale natural gas deliveries to Oracle's Texas data center. The company has secured multiple long term supply contracts totaling nearly 900 MMcf/d tied to this and related demand. Energy Transfer has paused its Lake Charles LNG project while it prioritizes U.S. natural gas infrastructure expansion, including the Desert Southwest project. For a company known primarily for long haul pipelines and export oriented projects, NYSE:ET is now putting more...

Kite Realty Group Trust reported past fourth-quarter 2025 revenue of US$204.94 million and net income of US$180.82 million, alongside full-year 2025 revenue of US$844.37 million and net income of US$298.66 million, and recently completed US$300.04 million in share repurchases while affirming a first-quarter 2026 dividend of US$0.29 per share. The sharp improvement in profitability, combined with meaningful share repurchases and a higher dividend, points to management’s confidence in the...

Elliott Investment Management’s campaign for broad board and leadership changes at Norwegian Cruise Line Holdings (NCLH) has put governance, execution, and long term direction in sharp focus for current and prospective shareholders. See our latest analysis for Norwegian Cruise Line Holdings. The share price has reacted strongly around this governance shake up, with a 2.40% 1 day share price return building on a 13.12% 7 day and 36.96% 90 day share price return. However, the 5 year total...

Sharplink (NasdaqCM:SBET) has launched a full brand refresh with a new Ethereum focused tagline. The company reports a larger institutional investor base alongside growth in its ETH treasury and staking rewards. These changes highlight Sharplink’s push to position itself as a leading corporate holder and manager of Ethereum. Sharplink, trading at $6.72 under ticker NasdaqCM:SBET, is drawing fresh attention as it links its brand directly to Ethereum and scales up its institutional investor...

Recently, Crinetics Pharmaceuticals reported encouraging Phase 2 data in congenital adrenal hyperplasia, showing that a meaningful share of patients in Cohort 4 achieved the same primary endpoint planned for Phase 3, while also highlighting early commercial traction for its FDA-approved oral acromegaly therapy, Palsonify. The combination of positive trial results and an expanding oral endocrine portfolio has reinforced analysts’ confidence in Crinetics’ late-stage pipeline and its potential...

Newmont Corporation reported fourth-quarter 2025 sales of US$6,818 million and full-year sales of US$22.67 billion, with full-year net income of US$7.09 billion and a fourth-quarter cash dividend of US$0.26 per share declared in February 2026 for payment on 26 March 2026. Despite record full-year earnings and a higher dividend, Newmont guided to lower attributable gold production of about 5.3 million ounces in 2026, alongside higher expected capital spending and an ongoing dispute over the...

Warren Buffett steps down from Berkshire Hathaway, with Greg Abel taking over leadership of NYSE:BRK.B. The transition comes alongside changes in Berkshire’s investment portfolio, including reduced exposure to some high profile holdings and new positions elsewhere. Subsidiary PacifiCorp agrees to a large wildfire settlement, creating potential financial and operational implications for the broader group. Berkshire Hathaway is a diversified holding company with interests across insurance,...